dydrogesterone has been researched along with Endometrial Hyperplasia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H | 1 |
| El Behery, MM; Ibrahiem, MA; Kamal, EM; Kassem, GA; Mohamed, Mel S; Saleh, HS | 1 |
| Bühling, KJ; Mueck, AO; Seeger, H | 1 |
| Schindler, AE | 1 |
| PLUNKETT, ER | 1 |
| Chernukha, GE; Davydova, MP; Samoilova, TE; Slukina, TV; Smetnik, VP; Sukhikh, GT; Zhdanov, AV | 1 |
| Burch, DJ; Jesinger, DK; Randall, S; Smith, SK; Spowart, KJ | 1 |
| Bergeron, C; Fox, H | 1 |
| King, RJ; Lane, G; Pryse-Davies, J; Ryder, TA; Siddle, NC; Whitehead, MI | 1 |
| Darragh, A | 1 |
3 review(s) available for dydrogesterone and Endometrial Hyperplasia
| Article | Year |
|---|---|
Use of dydrogesterone in hormone replacement therapy.
Topics: Breast Neoplasms; Cardiovascular Diseases; Drug Therapy, Combination; Dydrogesterone; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Progestins | 2009 |
Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
Topics: Animals; Dydrogesterone; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menstruation Disturbances; Progesterone; Progestins | 2009 |
Low incidence of endometrial hyperplasia with acceptable bleeding patterns in women taking sequential hormone replacement therapy with dydrogesterone.
Topics: Adult; Double-Blind Method; Dydrogesterone; Endometrial Hyperplasia; Estradiol; Female; Hormone Replacement Therapy; Humans; Incidence; Middle Aged; Postmenopause; Uterine Hemorrhage | 2000 |
2 trial(s) available for dydrogesterone and Endometrial Hyperplasia
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
Topics: Administration, Oral; Adult; Dydrogesterone; Egypt; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Satisfaction; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Ultrasonography | 2015 |
A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dydrogesterone; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Postmenopause; Prospective Studies; Uterine Hemorrhage | 1995 |
5 other study(ies) available for dydrogesterone and Endometrial Hyperplasia
| Article | Year |
|---|---|
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence | 2018 |
DRUGS FOR FUNCTIONAL UTERINE BLEEDING.
Topics: Contraceptive Agents; Contraceptives, Oral; Diethylstilbestrol; Dosage Forms; Drug Therapy; Dydrogesterone; Endometrial Hyperplasia; Estradiol; Estrone; Female; Humans; Injections, Intramuscular; Progesterone; Progestins; Toxicology; Uterine Hemorrhage | 1964 |
Disorders in cytokine gene expression in endometrial hyperplasia and effect of hormone therapy.
Topics: Apoptosis; Cell Proliferation; Cells, Cultured; Cytokines; Dydrogesterone; Endometrial Hyperplasia; Female; Gene Expression; Goserelin; Humans; RNA, Messenger | 2005 |
Effects of dydrogesterone on the oestrogenized postmenopausal endometrium.
Topics: Cell Nucleus; DNA; Dose-Response Relationship, Drug; Dydrogesterone; Endometrial Hyperplasia; Endometrium; Epithelium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Microscopy, Electron; Receptors, Estradiol | 1986 |
Indications for therapy with progestational agents.
Topics: Breast Diseases; Contraceptives, Oral; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Ethisterone; Ethynodiol Diacetate; Female; Humans; Male; Medroxyprogesterone; Menstruation Disturbances; Mental Disorders; Migraine Disorders; Norethindrone; Progesterone; Progestins; Sexual Dysfunction, Physiological | 1970 |